Abera seeks an enthousiastic PhD student for participation in the EU funded ITN program VacPath that is aimed at developing novel vector-based vaccines against Chlamydia trachomatis. Please click the link below to download the full job description:
Get in contact with us via the contact form or email: info@aberabio.com
Abera Bioscience is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from the Swedish protein production company Xbrane Bioscience.